Articles Published in 2013

Allergan, Medytox enter licensing agreement

Friday, September 27, 2013 10:49 AM

Allergan, a multi-specialty healthcare company, and Medytox, a research-based biopharmaceutical company, have entered into a license agreement. Allergan will pay Medytox an upfront payment of $65 million and Medytox will grant Allergan exclusive rights, worldwide outside of Korea, to develop and, if approved, commercialize neurotoxin product candidates currently in development, including a potential liquid-injectable product.

More... »

Pacific Biosciences, Roche ink agreement for clinical diagnostics

Friday, September 27, 2013 10:43 AM

Pacific Biosciences of California, provider of the PacBio RS II DNA Sequencing System, has entered into an agreement with Roche Diagnostics to develop diagnostic products, including sequencing systems and consumables, based on Pacific Biosciences' Single Molecule, Real-Time (SMRT) technology.

More... »

Ipsen to relocate R&D activities to Cambridge, Mass.

Friday, September 27, 2013 10:28 AM

Ipsen plans to relocate its U.S. R&D operations to Cambridge, Mass., in 2014. This site will be key for innovation in targeted therapies across Ipsen's specialty areas as well as a center of excellence for peptides. The move also brings Ipsen closer to several key partners based in the Cambridge area, including prominent hospital centers, medical schools, biotech companies and universities, thereby further promoting and facilitating partnerships and open innovation.

More... »

Quintiles undertakes genomic “pre-profiling” feasibility study

Friday, September 27, 2013 10:22 AM

CRO Quintiles has announced plans to improve the development of biomarker-targeted therapies through a novel approach that promotes the genomic “pre-profiling” of cancer patients. Quintiles is undertaking a study with the participation of U.S. Oncology Research, supported by McKesson Specialty Health and The U.S. Oncology Network, to explore the operational feasibility and clinical benefits of an upfront approach to the genomic profiling of tumors from metastatic colorectal cancer (mCRC) patients. The study will investigate how pre-profiling and genomic sequencing data may support physician treatment decisions, including the identification of appropriate clinical trials for patients.

More... »

Accelovance joins iMedNet Partner Program

Friday, September 27, 2013 10:19 AM

Accelovance, a CRO focused in early phase oncology, vaccines and general medicine development, has joined the iMedNet Partner Program, established by MedNet, a global life sciences technology company specializing in clinical study management systems. Accelovance now can offer iMedNet EDC to clients as an advanced solution for the data management needs associated with clinical trial programs while providing significant cost savings compared with similar platforms.

More... »

Gentris, BioFortis partner

Wednesday, September 25, 2013 03:14 PM

Gentris, a global provider of pharmacogenomics and biorepository solutions, has partnered with BioFortis to integrate its Labmatrix and Qiagram software into Gentris' laboratory operations. The Labmatrix and Qiagram software will provide an advanced platform for clients to view and manage samples housed in the Gentris biorepository, while simultaneously enhancing their ability to collect, harmonize and integrate multiple data sources, including clinical, molecular, patient and biospecimen data.

More... »

Almac launches SupplyTraQ technology solution

Wednesday, September 25, 2013 03:13 PM

Almac has launched SupplyTraQ, a web-based drug accountability and reconciliation tool that improves clinical trial drug supply management and simplifies post-trial administration. Compatible with IXRS, the company’s IVR/IWR technology, SupplyTraQ enables users to capture drug supply data in real-time and improve the accuracy of the supply management process. 

More... »

Amgen, ShanghaiTech University plans for Amgen China R&D center

Wednesday, September 25, 2013 03:12 PM

Amgen and ShanghaiTech University have partnered for the advancement of biopharmaceutical discovery and translational research in China, with plans for Amgen to open a China R&D center at ShanghaiTech University.

More... »

X-Chem achieves milestones, licenses drug discovery programs to AstraZeneca

Wednesday, September 25, 2013 02:43 PM

X-Chem, a privately-held biotechnology company focused on applying its drug discovery capabilities to the generation of novel small molecule therapeutics, has achieved several milestones leading to the licensing of three drug discovery programs by AstraZeneca, in the context of a collaboration the companies established in May 2012.

More... »

Wolters Kluwer Health launches Lippincott mobile nursing app

Wednesday, September 25, 2013 12:37 PM

Wolters Kluwer Health, a global provider of information and point-of-care solutions, has launched the Lippincott’s Nursing Advisor app, the first mobile application of an online clinical decision support solution for nurses. 

More... »